Exact Mass: 271.204837

Exact Mass Matches: 271.204837

Found 35 metabolites which its exact mass value is equals to given mass value 271.204837, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Tridecanoylglycine

2-tridecanamidoacetic acid

C15H29NO3 (271.2147324)


Tridecanoylglycine is an acylglycine with C-13 fatty acid group as the acyl moiety. Acylglycines 1 possess a common amidoacetic acid moiety and are normally minor metabolites of fatty acids. Elevated levels of certain acylglycines appear in the urine and blood of patients with various fatty acid oxidation disorders. They are normally produced through the action of glycine N-acyltransferase which is an enzyme that catalyzes the chemical reaction: acyl-CoA + glycine ↔ CoA + N-acylglycine. Margaroylglycine is an acylglycine with C-13 fatty acid group as the acyl moiety.

   

N-Lauroyl Alanine

2-[(1-Hydroxydodecylidene)amino]propanoate

C15H29NO3 (271.2147324)


N-lauroyl alanine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Lauric acid amide of Alanine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Lauroyl Alanine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Lauroyl Alanine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

3-(1-Adamantyl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine

3-(1-Adamantyl)-6,7,8,9-tetrahydro-5H-(1,2,4)triazolo(4,3-a)azepine

C17H25N3 (271.204837)


   

N-LAUROYLSARCOSINE

N-Methyl-N-(1-oxododecyl)glycine sodium salt (1:1)

C15H29NO3 (271.2147324)


D013501 - Surface-Active Agents > D003902 - Detergents

   
   

N-LAUROYLSARCOSINE

N-Dodecanoyl-N-methylglycine

C15H29NO3 (271.2147324)


D013501 - Surface-Active Agents > D003902 - Detergents CONFIDENCE standard compound; INTERNAL_ID 683; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5609; ORIGINAL_PRECURSOR_SCAN_NO 5607 CONFIDENCE standard compound; INTERNAL_ID 683; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5625; ORIGINAL_PRECURSOR_SCAN_NO 5623 CONFIDENCE standard compound; INTERNAL_ID 683; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5581; ORIGINAL_PRECURSOR_SCAN_NO 5579 CONFIDENCE standard compound; INTERNAL_ID 683; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5616; ORIGINAL_PRECURSOR_SCAN_NO 5612 CONFIDENCE standard compound; INTERNAL_ID 683; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5614; ORIGINAL_PRECURSOR_SCAN_NO 5611 CONFIDENCE standard compound; INTERNAL_ID 683; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10228; ORIGINAL_PRECURSOR_SCAN_NO 10227 CONFIDENCE standard compound; INTERNAL_ID 683; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10277; ORIGINAL_PRECURSOR_SCAN_NO 10275 CONFIDENCE standard compound; INTERNAL_ID 683; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10291; ORIGINAL_PRECURSOR_SCAN_NO 10289 CONFIDENCE standard compound; INTERNAL_ID 683; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10331; ORIGINAL_PRECURSOR_SCAN_NO 10326 CONFIDENCE standard compound; INTERNAL_ID 683; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10341; ORIGINAL_PRECURSOR_SCAN_NO 10339 CONFIDENCE standard compound; INTERNAL_ID 683; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10348; ORIGINAL_PRECURSOR_SCAN_NO 10347 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 1012

   

(2R,4S,6R,2S)-N-methyl-2-(2-oxo-butyl)-6-(2-hydroxyamyl)-piperidin-4-ol|lobechidine B

(2R,4S,6R,2S)-N-methyl-2-(2-oxo-butyl)-6-(2-hydroxyamyl)-piperidin-4-ol|lobechidine B

C15H29NO3 (271.2147324)


   

2-formylamido-3-acetoxydodecane|clavaminol L

2-formylamido-3-acetoxydodecane|clavaminol L

C15H29NO3 (271.2147324)


   

tBuO-val-hexanoate (tert-butyl hexanoylvalinate)

tBuO-val-hexanoate (tert-butyl hexanoylvalinate)

C15H29NO3 (271.2147324)


   

2-tert-Butyl-N-piperidin-4-yl-1H-indol-5-amine

2-tert-Butyl-N-piperidin-4-yl-1H-indol-5-amine

C17H25N3 (271.204837)


   

N-Dodecanoyl-L-alanine

N-Dodecanoyl-L-alanine

C15H29NO3 (271.2147324)


   

N,N-bis(2-hydroxyethyl)undecenamide

N,N-bis(2-hydroxyethyl)undecenamide

C15H29NO3 (271.2147324)


   
   

N-Dodecanoyl-alanine

N-Dodecanoyl-alanine

C15H29NO3 (271.2147324)


   

5-Amino-6-cyclohexyl-4-hydroxy-2-isopropyl-hexanoic acid

5-Amino-6-cyclohexyl-4-hydroxy-2-isopropyl-hexanoic acid

C15H29NO3 (271.2147324)


   

[Dodecanoyl(methyl)amino]acetate

[Dodecanoyl(methyl)amino]acetate

C15H29NO3 (271.2147324)


   

N-[(E)-1,3-dihydroxytridec-4-en-2-yl]acetamide

N-[(E)-1,3-dihydroxytridec-4-en-2-yl]acetamide

C15H29NO3 (271.2147324)


   

N-[(E)-1,3-dihydroxyoct-4-en-2-yl]heptanamide

N-[(E)-1,3-dihydroxyoct-4-en-2-yl]heptanamide

C15H29NO3 (271.2147324)


   

N-[(E)-1,3-dihydroxynon-4-en-2-yl]hexanamide

N-[(E)-1,3-dihydroxynon-4-en-2-yl]hexanamide

C15H29NO3 (271.2147324)


   

N-[(E)-1,3-dihydroxyundec-4-en-2-yl]butanamide

N-[(E)-1,3-dihydroxyundec-4-en-2-yl]butanamide

C15H29NO3 (271.2147324)


   

N-[(E)-1,3-dihydroxydec-4-en-2-yl]pentanamide

N-[(E)-1,3-dihydroxydec-4-en-2-yl]pentanamide

C15H29NO3 (271.2147324)


   

N-[(E)-1,3-dihydroxydodec-4-en-2-yl]propanamide

N-[(E)-1,3-dihydroxydodec-4-en-2-yl]propanamide

C15H29NO3 (271.2147324)


   

N-tridecanoylglycine

N-tridecanoylglycine

C15H29NO3 (271.2147324)


An N-acylglycine with an acyl group that is tridecanoyl.

   
   
   
   
   
   

(1s,9s,10r)-9-[(2z)-hex-2-en-1-yl]-10-methyl-5,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-4(12),7-dien-6-imine

(1s,9s,10r)-9-[(2z)-hex-2-en-1-yl]-10-methyl-5,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-4(12),7-dien-6-imine

C17H25N3 (271.204837)


   

n-[(2r,3s)-3-(acetyloxy)dodecan-2-yl]methanimidic acid

n-[(2r,3s)-3-(acetyloxy)dodecan-2-yl]methanimidic acid

C15H29NO3 (271.2147324)


   

(1s,9r,10r)-9-(hex-2-en-1-yl)-10-methyl-5,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-4(12),7-dien-6-imine

(1s,9r,10r)-9-(hex-2-en-1-yl)-10-methyl-5,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-4(12),7-dien-6-imine

C17H25N3 (271.204837)


   

(1s,9r,10r)-9-[(2z)-hex-2-en-1-yl]-10-methyl-5,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-4(12),7-dien-6-imine

(1s,9r,10r)-9-[(2z)-hex-2-en-1-yl]-10-methyl-5,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-4(12),7-dien-6-imine

C17H25N3 (271.204837)


   

n-[3-(acetyloxy)dodecan-2-yl]methanimidic acid

n-[3-(acetyloxy)dodecan-2-yl]methanimidic acid

C15H29NO3 (271.2147324)


   

9-(hex-2-en-1-yl)-10-methyl-5,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-4(12),7-dien-6-imine

9-(hex-2-en-1-yl)-10-methyl-5,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-4(12),7-dien-6-imine

C17H25N3 (271.204837)